Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 236 (8%) | |
| Anticipated shortage: | 18 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
29 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2023-06-16 | 2023-07-13 | 195086 |
| APO-OXYBUTYNIN | 5 MG | TABLET | Resolved | 2017-03-10 | 2017-04-03 | 414 |
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-04-07 | 2018-11-30 | 5865 |
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-06-28 | 2018-11-30 | 14201 |
| APO-OXYCODONE CR | 10.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2018-05-16 | 417 |
| APO-OXYCODONE CR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-11 | 2018-09-19 | 420 |
| APO-OXYCODONE CR | 20.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-11 | 2017-05-24 | 423 |
| APO-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-02 | 2017-06-05 | 8615 |
| APO-OXYCODONE CR | 5.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-25 | 2017-10-03 | 16912 |
| APO-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-26 | 2017-10-24 | 17260 |
| APO-OXYCODONE CR | 80.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-26 | 2017-09-22 | 17263 |
| APO-OXYCODONE CR | 20.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-10-11 | 2018-03-13 | 25304 |
| APO-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-12-20 | 2018-03-21 | 33867 |
| APO-OXYCODONE CR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-18 | 2019-02-08 | 69921 |
| APO-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-27 | 2020-03-02 | 99792 |
| APO-OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2021-04-05 | 2021-06-28 | 136808 |
| APO-OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2021-12-24 | 2022-03-21 | 151889 |
| APO-OXYCODONE CR | 5.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-07-22 | 2022-09-23 | 165332 |
| APO-OXYCODONE CR | 20.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-09 | 2023-01-26 | 177612 |
| APO-OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-26 | 2023-08-12 | 193224 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
| APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
| APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |